Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only and should never be considered medical advice and should never be acted on without review with your health care team.

CLL Society Education On Demand: Is There Good News Ahead? Update on Omicron and Beyond / Available Therapies for COVID-19

Recorded Friday, March 18, 2022


As we enter our third year of the COVID-19 pandemic with the rise of the Omicron variant and promising news from the scientific community about more therapeutic options for those who are infected with COVID-19 and options for pre-exposure prophylaxis, we remain hopeful for the future.

Join infectious disease specialist Dr. Joshua Hill and CLL expert Dr. Sameer Parikh who will give brief updates about where we are today and then spend the majority of the event answering your questions.  It is critical that CLL patients and caregivers continue to receive up-to-date and credible information from a spectrum of expert voices.


Robyn Brumble, MSN, RN
Director of Scientific Affairs and Research
CLL Society


Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd
Executive Vice President and Chief Medical Officer
CLL Society


Joshua A. Hill, MD
Assistant Professor
Vaccine and Infectious Disease Division and Clinical Research Division
Fred Hutch

Sameer Parikh - CLL Society


Sameer Parikh, MD, MBBS
Assistant Professor of Medicine, Hematology
Consultant, Division of Hematology
Mayo Clinic

This program was made possible by grant support from Regeneron, Pharmacyclics, and Janssen.